MIRA
INFORM REPORT
|
Report Date : |
02.12.2011 |
IDENTIFICATION DETAILS
|
Name : |
PHOENIX BIOLOGICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Flat No.6, New No.3, Old No.2, |
|
|
|
|
Country : |
|
|
|
|
|
Date of
Incorporation : |
30.07.2010 |
|
|
|
|
Com. Reg. No.: |
18-076804 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 0.100 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24100TN2010PTC076804 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturers
and Exporters of Pharmaceutical Products. |
|
|
|
|
No. of Employees
: |
50 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca (11) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
New Company |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a relatively new company and yet to established itself
gradually. Business is active. Payment terms are unknown. The company can be considered for business dealings on a secured trade
terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Subramanian Venkatraman |
|
Designation : |
Director |
|
Contact No.: |
91-8939931625 |
|
Date : |
28.11.2011 |
LOCATIONS
|
Registered Office : |
Flat No.6, New No.3, Old No.2, |
|
Tel. No.: |
Not Available |
|
Mobile No.: |
91-8939914070 (Mr. R. Chockalingam) 91-8939931625 (Mr. S. Venkatraman) |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
600 sq. ft. |
|
Location : |
Owned |
|
|
|
|
Administrative Office : |
No.4/25-B, Valluvar Salai, Ramapuram, Chennai – 600 089, |
|
Tel. No.: |
91-44-22494524 |
|
Area : |
1000 sq. ft. |
|
Location : |
Rented |
|
|
|
|
Factory : |
Located at: v
Puducherry, Tamilnadu |
|
Area : |
14000 sq ft |
|
Location : |
Owned |
DIRECTORS
|
Name : |
Mr. Chockalingam Ramakrishnan |
||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||
|
Address : |
Plot No. 7, 8, 9, Flat No. B-4, R.R. Omkar Flats, |
||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
10.02.1968 |
||||||||||||||||||||||||||||||||||||
|
Qualification : |
Pharm Graduate |
||||||||||||||||||||||||||||||||||||
|
Experience : |
20 Years |
||||||||||||||||||||||||||||||||||||
|
E-Mail : |
|||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
30.07.2010 |
||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02010667 |
||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Subramanian Venkatraman |
||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||
|
Address : |
Flat No. 7, Nathans Flats, Old No. 9, 25, Srinivas Pillai Street, West
Mambalam, Chennai – 600 033, Tamilnadu, India |
||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
15.03.1965 |
||||||||||||||||||||||||||||||||||||
|
Qualification : |
P. G. Marketing |
||||||||||||||||||||||||||||||||||||
|
Experience : |
25 Years |
||||||||||||||||||||||||||||||||||||
|
E-Mail : |
|||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
30.07.2010 |
||||||||||||||||||||||||||||||||||||
|
DIN No.: |
02370397 |
||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
|
Names of Shareholders |
|
No. of Shares |
|
S. Venkatraman |
|
5000 |
|
R. Chockalingam |
|
5000 |
|
Total |
|
10000 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturers
and Exporters of Pharmaceutical Products. |
|
|
|
|
Products : |
|
|
|
|
|
Exports : |
|
|
Products : |
Pharmaceutical Products |
|
Countries : |
v
South Asian v
|
|
|
|
|
Terms : |
|
|
Selling : |
L/C and T.T. |
|
|
|
|
Purchasing : |
L/C and T.T. |
GENERAL INFORMATION
|
Customers : |
Manufacturer and Companies |
|
|
|
|
No. of Employees : |
50 (Approximately) |
|
|
|
|
Bankers : |
Indian Overseas Bank, West Mambalam Branch, 16, Thiruvengadam Street,
West Mambalam, Chennai – 600 033, Tamilnadu, India |
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Vatlaguda and Associates Chartered Accountants |
|
Address : |
Chennai, |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50000 |
Equity Shares |
Rs.10/- each |
Rs. 0.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs.10/- each |
Rs. 0.100 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
|
Particulars |
|
|
31.03.2011 |
|
Sales Turnover (Approximately) |
|
|
24.000 |
|
|
|
|
|
Expected Sales (2011-2012): Rs.25.000 millions
The above information has been parted by Mr. Subramanian Venkatraman (Director).
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info Agents |
Available in Report (Yes / No) |
|
1) Year of
Establishment |
Yes |
|
2) Locality of
the firm |
Yes |
|
3) Constitutions
of the firm |
Yes |
|
4) Premises
details |
Yes |
|
5) Type of
Business |
Yes |
|
6) Line of
Business |
Yes |
|
7) Promoter’s
background |
-- |
|
8) No. of
employees |
Yes |
|
9) Name of person
contacted |
Yes |
|
10) Designation
of contact person |
Yes |
|
11) Turnover of
firm for last three years |
-- |
|
12) Profitability
for last three years |
No |
|
13) Reasons for
variation <> 20% |
Yes |
|
14) Estimation
for coming financial year |
Yes |
|
15) Capital in
the business |
Yes |
|
16) Details of
sister concerns |
-- |
|
17) Major
suppliers |
No |
|
18) Major
customers |
Yes |
|
19) Payments
terms |
Yes |
|
20) Export /
Import details (if applicable) |
Yes |
|
21) Market
information |
-- |
|
22) Litigations
that the firm / promoter involved in |
-- |
|
23) Banking
Details |
Yes |
|
24) Banking
facility details |
No |
|
25) Conduct of
the banking account |
-- |
|
26) Buyer visit
details |
-- |
|
27) Financials,
if provided |
No |
|
28) Incorporation
details, if applicable |
-- |
|
29) Last accounts
filed at ROC |
-- |
|
30) Major
Shareholders, if available |
-- |
FORM 8:
|
Corporate
identity number of the company |
U24100TN2010PTC076804 |
||||
|
Name of the
company |
PHOENIX BIOLOGICALS PRIVATE LIMITED |
||||
|
Address of the
registered office or of the principal place of business in |
Flat No.6, New No.3, Old No.2, E-Mail: phoenixbiologicals@gmail.com |
||||
|
This form is for |
Creation of
charge |
||||
|
Type of charge |
Movable Property Others (Vehicles)
|
||||
|
Particular of
charge holder |
Indian Overseas Bank, West Mambalam Branch, 16, Thiruvengadam Street,
West Mambalam, Chennai – 600 033, Tamilnadu, India E-Mail: wstmbbr@chemrc01.iobnet.co.in |
||||
|
Nature of
description of the instrument creating or modifying the charge |
Deed of
hypothecation. |
||||
|
Date of
instrument Creating the charge |
14.07.2011 |
||||
|
Amount secured by
the charge |
Rs.1.600 millions
|
||||
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest: 13.25% p.a.
(Floating) with monthly rests. Terms of
Repayment: Repayable in 60
monthly installments of Rs.0.037 million each. Commencing From 31.08.2011. Margin: As determined by
the bank from time to time. Extent and
Operation of the charge: Hypothecation of
2 Nos. of FIAT LINEA CARS purchased out of Term Loan. (1) Chasis
No.MCA11031B09025861DMZ, (2)MCA11031B09025862DMZ (1) Engine
No.148751, (2) 149066. Others:
All other terms
and conditions as per sanction letter / instruments executed. |
||||
|
Short particulars
of the property charged |
Hypothecation of
2 Nos. of FIAT LINEA CARS purchased out of Term Loan. (1) Chasis
No.MCA11031B09025861DMZ, (2)MCA11031B09025862DMZ (1) Engine
No.148751, (2) 149066. |
TRADE REFERENCES:
v Tablex Limited
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.65 |
|
|
1 |
Rs.81.05 |
|
Euro |
1 |
Rs.69.50 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
2 |
|
PAID-UP CAPITAL |
1~10 |
2 |
|
OPERATING SCALE |
1~10 |
2 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
2 |
|
--PROFITABILIRY |
1~10 |
- |
|
--LIQUIDITY |
1~10 |
2 |
|
--LEVERAGE |
1~10 |
1 |
|
--RESERVES |
1~10 |
- |
|
--CREDIT LINES |
1~10 |
- |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
11 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.